Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00448175 · ClinicalTrials.gov registry record · Phase 4
Overactive Bladder Innovative Therapy Trial (OrBIT)
A Phase 4 study of Overactive Bladder, sponsored by Uroplasty.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT00448175: Completed Phase 4 study of Overactive Bladder, sponsored by Uroplasty.
NCT00448175 is a Phase 4 study of Overactive Bladder that has completed, run by Uroplasty. The registered enrollment target is 100 participants, below the 205-participant average among 46 other Overactive Bladder trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00448175, a Phase 4 study of Overactive Bladder, has completed, sponsored by Uroplasty.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare percutaneous tibial nerve stimulation (PTNS) to drug therapy for the treatment of symptoms of overactive bladder (OAB).
Primary Outcome
To demonstrate that the Urgent PC system is as effective as or more effective (noninferior) than tolterodine (Detrol LA) in changing the frequency of urinary voids per day after 12 weeks of therapy. The voiding diaries completed at 12 weeks were compared to the baseline voiding diaries.
Conditions Studied
Interventions
- DEVICE Urgent PC Neuromodulation System
- DRUG Tolterodine
Study Locations (1)
Minnesota
- Uroplasty, Inc - Minnetonka
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-10 |
| Phase | Phase 4 |
What the finished NCT00448175 record still lists
NCT00448175 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 205-participant average among 46 other Overactive Bladder trials with a reported enrollment target (51% lower).
The record links to 1 condition, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which Urgent PC Neuromodulation System is the first listed.
NCT00448175 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00448175 about?
NCT00448175 is a clinical study titled "Overactive Bladder Innovative Therapy Trial (OrBIT)". The purpose of this study is to compare percutaneous tibial nerve stimulation (PTNS) to drug therapy for the treatment of symptoms of overactive bladder (OAB).
What is the current status of trial NCT00448175?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2006-06. Estimated completion is 2008-10.
What conditions does trial NCT00448175 study?
This clinical trial studies the following conditions: Overactive Bladder.
What interventions are being tested in trial NCT00448175?
The interventions under investigation include: Urgent PC Neuromodulation System (DEVICE), Tolterodine (DRUG).
Who is sponsoring clinical trial NCT00448175?
This trial is sponsored by Uroplasty, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00448175 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overactive Bladder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00448175's enrollment target sits among peer trials
100 23rd of 46 higher than 22 of 46 other Overactive Bladder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overactive Bladder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Bladder Botox UTI Antibiotic Prophylaxis
RECRUITING · Phase 4
-
Standard Injections Versus Reduced Injections for Intravesical onabotulinumtoxinA Treatment of Overactive Bladder
RECRUITING · Phase 4
-
Urinary Microbiome Changes Following Administration of 500 mg of NDS-446 in Women With Dry OAB at 12 Weeks
RECRUITING · Phase 4
-
TReating Incontinence for Underlying Mental and Physical Health
RECRUITING · Phase 4
-
Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder
COMPLETED · Phase 4
-
Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia